Literature DB >> 18514391

Type 2 iodothyronine deiodinase is highly expressed in medullary thyroid carcinoma.

Erika L Souza Meyer1, Iuri M Goemann, José Miguel Dora, Marcia S Wagner, Ana Luiza Maia.   

Abstract

Type II deiodinase (D2) plays a critical role in controlling intracellular T3 concentration and early studies indicated a follicular but not a parafollicular C-cell origin of D2 activity in the thyroid gland. Here, we show that D2 is highly expressed in human medullary thyroid carcinoma (MTC), a tumor that arises from the C-cells. D2 transcripts were detected in all MTC samples obtained from 12 unselected MTC patients and the levels of D2 activity were comparable to those found in surrounding normal follicular tissue (0.41+/-0.10 fmol min mg protein vs. 0.43+/-0.41 fmol min mg protein, P=0.91). Additional analysis in the TT cells, a human MTC cell line, demonstrated that the D2 expression is downregulated by thyroid hormones and enhanced by cAMP analogs and dexamethasone. The thyroid hormone receptor alpha1 and beta isoforms were also detected in all MTC samples and in TT cells, thus suggesting a potential role of T3 locally produced by D2 in this neoplastic tissue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514391      PMCID: PMC2527534          DOI: 10.1016/j.mce.2008.04.009

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  48 in total

1.  Pituitary cells respond to thyroid hormone by discrete, gene-specific pathways.

Authors:  A L Maia; J W Harney; P R Larsen
Journal:  Endocrinology       Date:  1995-04       Impact factor: 4.736

2.  Hormonal control of a low Km (type II) iodothyronine 5'-deiodinase in cultured NB41A3 mouse neuroblastoma cells.

Authors:  D L St Germain
Journal:  Endocrinology       Date:  1986-08       Impact factor: 4.736

3.  Thyroid hormone affects the expression of neoplastic transformation induced by DNA-transfection.

Authors:  S W Leuthauser; D L Guernsey
Journal:  Cancer Lett       Date:  1987-06       Impact factor: 8.679

4.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

Authors:  L M Mulligan; J B Kwok; C S Healey; M J Elsdon; C Eng; E Gardner; D R Love; S E Mole; J K Moore; L Papi
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

Review 5.  [Iodothyronine deiodinases expression in thyroid neoplasias].

Authors:  Erika L Souza Meyer; Márcia S Wagner; Ana Luiza Maia
Journal:  Arq Bras Endocrinol Metabol       Date:  2007-07

6.  Thyroid influence on the growth of hepatoma HW-165 in Wistar rats.

Authors:  M Lemaire; W Baeyens; L de Saint-Georges; L Baugnet-Mahieu
Journal:  Biomedicine       Date:  1981-12

7.  Expression of thyrotropin receptor (TSH-R), thyroglobulin, thyroperoxidase, and calcitonin messenger ribonucleic acids in thyroid carcinomas: evidence of TSH-R gene transcript in medullary histotype.

Authors:  R Elisei; A Pinchera; C Romei; M Gryczynska; V Pohl; C Maenhaut; L Fugazzola; F Pacini
Journal:  J Clin Endocrinol Metab       Date:  1994-04       Impact factor: 5.958

8.  Thyroxine 5-deiodinase in human brain tumors.

Authors:  K Mori; K Yoshida; T Kayama; N Kaise; H Fukazawa; Y Kiso; K Kikuchi; Y Aizawa; K Abe
Journal:  J Clin Endocrinol Metab       Date:  1993-11       Impact factor: 5.958

9.  Point mutation of the RET proto-oncogene in the TT human medullary thyroid carcinoma cell line.

Authors:  F Carlomagno; D Salvatore; M Santoro; V de Franciscis; L Quadro; L Panariello; V Colantuoni; A Fusco
Journal:  Biochem Biophys Res Commun       Date:  1995-02-27       Impact factor: 3.575

10.  Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens.

Authors:  F Pacini; F Basolo; R Elisei; L Fugazzola; A Cola; A Pinchera
Journal:  Am J Clin Pathol       Date:  1991-03       Impact factor: 2.493

View more
  6 in total

Review 1.  Iodothyronine deiodinases and cancer.

Authors:  A Piekiełko-Witkowska; A Nauman
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

2.  IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells.

Authors:  Simone Magagnin Wajner; Iuri Martin Goemann; Ana Laura Bueno; P Reed Larsen; Ana Luiza Maia
Journal:  J Clin Invest       Date:  2011-04-11       Impact factor: 14.808

3.  Thyroid hormone deiodinases and cancer.

Authors:  Sabina Casula; Antonio C Bianco
Journal:  Front Endocrinol (Lausanne)       Date:  2012-06-01       Impact factor: 5.555

Review 4.  Deiodinases and Cancer.

Authors:  Annarita Nappi; Maria Angela De Stefano; Monica Dentice; Domenico Salvatore
Journal:  Endocrinology       Date:  2021-04-01       Impact factor: 4.736

5.  An Assessment of GPX1 (rs1050450), DIO2 (rs225014) and SEPP1 (rs7579) Gene Polymorphisms in Women with Endometrial Cancer.

Authors:  Magdalena Janowska; Natalia Potocka; Sylwia Paszek; Marzena Skrzypa; Kamila Żulewicz; Marta Kluz; Sławomir Januszek; Piotr Baszuk; Jacek Gronwald; Jan Lubiński; Izabela Zawlik; Tomasz Kluz
Journal:  Genes (Basel)       Date:  2022-01-21       Impact factor: 4.096

Review 6.  Thyroid hormones in diabetes, cancer, and aging.

Authors:  Benoit R Gauthier; Alejandro Sola-García; María Ángeles Cáliz-Molina; Petra Isabel Lorenzo; Nadia Cobo-Vuilleumier; Vivian Capilla-González; Alejandro Martin-Montalvo
Journal:  Aging Cell       Date:  2020-10-13       Impact factor: 9.304

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.